As the population ages, increasing cases of dementia, especially Alzheimer’s type are uncovered and diagnosed. The genetics of these conditions are rapidly being elucidated and have been of interest to the scientific community and the lay public alike. Genetic tests can suggest a higher degree of likelihood for patients to develop such conditions which, contrary to popular thought, is of value to patients in their normal routine of health care and preventative medicine. This webinar will focus on the complex genetics that seem to make us prone to such conditions as we age.
Arnold I. Pallay, M.D., FAAFP
Associate Director Jacobs Levy Personalized Genomic Medicine Program Atlantic Health System
Associate Clinical Professor Department of Family Medicine Rutgers Robert Wood Johnson Medical School and New Jersey Medical School Graduate School of Medicine, Seton Hall University
Dawn Van Dam
President & CEO
One Million Solutions in Health™